Amino Acids, Peptides & Proteins

GS-7340 is a novel prodrug of tenofovir, the active agent in Viread, or tenofovir disoproxil fumarate. In previous studies, GS-7340 has demonstrated the ability to provide greater antiviral efficacy at a dose that...

Filter cake is in the crosshairs at industrial biotech company Verenium Corp. The publicly held enzyme maker has developed an environmentally friendly alternative to the chemicals oil-drilling companies traditionally use to break down...

RESEARCH TRIANGLE PARK, N.C. -- BioCryst Pharmaceuticals, Inc., (NASDAQ:BCRX) today announced that Nancy J. Hutson, Ph.D. was elected to the Company's Board of Directors, effective Friday, January 20, 2012. "We are excited to...

Pharmacogenetic Patents Have the Potential to Extend Drug Candidate's Potential Commercial Exclusivity Period If Regulatory Approval Obtained BROOMFIELD, Colo. -- ARCA biopharma, Inc. (Nasdaq:ABIO), a biopharmaceutical company developing genetically targeted therapies for cardiovascular...

RESEARCH TRIANGLE PARK, N.C. -- Precision BioSciences, Inc., today announced the formation of Precision PlantSciences, Inc., a wholly owned subsidiary of Precision BioSciences. Precision PlantSciences will focus its efforts exclusively on the development...

Standard Use of Rave by Japanese Specialty Pharma Across All Trials Will Streamline Research, Accelerate Decision Making and Help Expand Global Network NEW YORK & OSAKA, Japan -- Medidata Solutions (NASDAQ: MDSO), a...

Professors David Kerr and Nick La Thangue offer oncology consulting and biomarker R&D activities spun out from the University of Oxford OXFORD, U.K. & RESEARCH TRIANGLE PARK, N.C. -- Continuing its commitment to...

ROCKVILLE, Md. -- Rexahn Pharmaceuticals, Inc. (NYSE Amex: RNN), a clinical stage pharmaceutical company developing and commercializing oncology and CNS therapeutics, today announced that it has secured Hungarian Regulatory Authority and Ethics Committee...

DUBLIN -- Research and Markets (http://www.researchandmarkets.com/research/dc66aa/osteoporosis_thera) has announced the addition of GlobalData 's new report "Osteoporosis Therapeutics - Pipeline Assessment and Market Forecasts to 2018" to their offering. The Osteoporosis Therapeutics Market is...

SHEFFIELD, England -- Simcyp Limited, the leader in modelling and simulation of drug-drug interactions in virtual human populations, today announces it has extended its animal models to include a virtual mouse. Laboratory mice...

MADISON, Wis. -- Promega announces the beta launch of the online gene exploration tool Find My Gene([TM]). Find My Gene integrates a number of robust functionalities to help researchers better understand their gene's...

MIAMI -- Data presented at the 6th Annual Human Amyloid Imaging (HAI) meeting in Miami suggest that the investigational imaging agent [18F] Flutemetamol could add value to current diagnostic tools used by physicians...

CAMBRIDGE, Mass. -- Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), a leading RNAi therapeutics company, announced today that it has filed a patent infringement lawsuit against Tekmira Pharmaceuticals Corporation in the U.S. District Court of...

ROCHESTER, Minn. -- An investigational drug called regorafenib slowed the progression of tumors and lengthened the lives of patients with metastatic colorectal cancer, an international phase III clinical trial found. The findings were...

According to Pfizer and Medivation, Dimebon (latrepirdine) failed to meet either of its co-primary endpoints in the Phase III trial. Over the course of 12 months, no statistically significant improvements were noted on...

DUBLIN -- Research and Markets (http://www.researchandmarkets.com/research/dd25b8/bsl3_and_bsl4_agen) has announced the addition of John Wiley and Sons Ltd's new book "BSL3 and BSL4 Agents: Proteomics, Glycomics, and Antigenicity" to their offering. Edited by leading experts...

ROCKVILLE, Md. -- Rexahn Pharmaceuticals, Inc. (NYSE Amex: RNN), a clinical stage pharmaceutical company commercializing oncology and CNS therapeutics, today provided guidance on its key pipeline, scientific and business goals for 2012. "Rexahn...

CARLSBAD, Calif. -- Verdezyne, Inc., a privately-held industrial biotechnology company focused on producing renewable chemicals and fuels from non-petroleum sources, has been granted a United States Patent on engineered microorganisms. Verdezyne was awarded...

BERLIN -- JPT Peptide Technologies GmbH (JPT), a wholly-owned subsidiary of BioNTech AG (Mainz, Germany), IUCT and LEITAT (Barcelona, Spain) announced today their collaboration on the joint development of an enhanced anticancer therapy...